drugset / Trial / NCT01109758

Effects of Fenofibrate on Gene Expression in Healthy Volunteers

NCT01109758

Phase 1 Completed 26 enrolled Solvay Pharmaceuticals
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to assess how fenofibrate modify gene expression in circulating monocytes of healthy volunteers after 6 weeks.

Timeline

Start
2008-03
Primary completion
2008-07
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 145 mg

Indications

No indication recorded.